Pharmafile Logo
Pharmafocus logo
Advanced Search

SMC

Showing 7 posts of 37 posts found.

Pfizer image

SMC approves Inlyta

November 13, 2013
Sales and Marketing Pfizer, SMC, Sutent, inylta, rcc

Pfizer’s kidney cancer drug Inlyta has been approved by the drugs watchdog in Scotland, making it the only country in …

News

SMC must be ‘more flexible’ – health minister

October 9, 2013
Sales and Marketing CDF, NICE, SMC

The Scottish health secretary Alex Neil has announced a series of fundamental changes to improve access to new medicines in …

News
scotland_flag_web

Scotland fund for rare diseases

January 17, 2013
Sales and Marketing SMC, Scotland, rare diseases

The Scottish government is launching a £21 million fund in March to meet the costs of patients who require orphan …

News
Eisai image

SMC first to give Fycompa thumbs-up

December 12, 2012
Sales and Marketing Eisai, Fycompa, SMC, Scotland, epilepsy

The Scottish Medicines Consortium (SMC) has approved Eisai’s first-in-class epilepsy drug Fycompa for use in the NHS in Scotland – …

News
Alex Neil

SMC put under review

November 20, 2012
Sales and Marketing Alex Neil, NICE, SMC, Scotland

The Scottish Medicines Consortium (SMC) has been put under the spotlight in two reviews ordered by Scotland’s health secretary Alex …

News
yervoy image

Scottish watchdog rejects Yervoy

May 14, 2012
Sales and Marketing BMS, Cancer, NICE, SMC, Yervoy, melanoma

The Scottish Medicines Consortium is not recommending Bristol-Myers Squibb’s melanoma treatment Yervoy.  The SMC said that Yervoy (ipilimumab), which has …

News

Head-to-head: Nice and the SMC

August 16, 2006
Research and Development, Sales and Marketing NICE, SMC, healthcare

The announcements on NHS budget deficits and the debates surrounding the prescribing of costly drugs, such as in the  Herceptin …

Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026